Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Interest & Investment Income (2019 - 2022)

Inventiva (IVA) posted quarterly Interest & Investment Income of $4.47 for Q2 2025, down 100.0% year-over-year from $4.3 million in Q2 2024, and down 100.0% quarter-over-quarter from $5.6 million in Q4 2024.

Analysis

Inventiva (IVA) Interest & Investment Income (2019 - 2022) Analysis & Trends

Inventiva's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $4.47 for Q2 2025.

  • In Q2 2025, Interest & Investment Income fell 100.0% year-over-year to $4.47; the TTM figure through Jun 2025 stood at $4.47 (down 100.0% YoY), while the FY2025 annual figure was $4.9 million, down 12.98% from the prior year.
  • Interest & Investment Income for Q2 2025 stood at $4.47, down from $5.6 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $5.6 million in Q4 2024, with the low at $4.47 in Q2 2025.
  • The 4-year median for Interest & Investment Income is $3.7 million (2023), against an average of $3.1 million.
  • The sharpest annual moves came in 2021 and 2025: Interest & Investment Income soared 20026.9% in 2021, then tumbled 100.0% in 2025.
  • Inventiva's Interest & Investment Income stood at $1.9 million in 2021, then jumped by 92.42% to $3.7 million in 2023, then surged by 52.23% to $5.6 million in 2024, then sank by 100.0% to $4.47 in 2025.
  • Business Quant data shows IVA's Interest & Investment Income at $4.47 in Q2 2025, $5.6 million in Q4 2024, and $4.3 million in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.06 Mn
Jun 30, 2021 1.90 Mn
Mar 31, 2021 4.44 Mn
Dec 31, 2020 -4.65 Mn
Jun 30, 2020 30,840.88
Mar 31, 2020 22,078.78
Dec 31, 2019 102,940.55